Linda Llewelyn Health Catalyst, Inc. (HCAT) insider trading activity

Linda Llewelyn is Chief People Officer of Health Catalyst, Inc.. Currently has a direct ownership of 116,923 shares of HCAT, which is worth approximately $852,368. The most recent transaction as insider was on Dec 01, 2022, when has been sold 3,557 shares (Common Stock) at a price of $10.65 per share, resulting in proceeds of $37,882. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K

4.51% 3M change

42.5% 12M change

Total Value Held $852,368

Linda Llewelyn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2022	SELL Payment of exercise price or tax liability	$37,882 $10.65 p/Share	3,557 Reduced 6.52%	50,991 Common Stock
Nov 15 2022	SELL Open market or private sale	$7,238 $10.82 p/Share	669 Reduced 1.21%	54,548 Common Stock
Oct 18 2022	SELL Open market or private sale	$6,175 $9.53 p/Share	648 Reduced 1.16%	55,217 Common Stock
Sep 15 2022	SELL Open market or private sale	$7,122 $10.99 p/Share	648 Reduced 1.15%	55,865 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$9,845 $11.61 p/Share	848 Reduced 1.48%	56,513 Common Stock
Aug 15 2022	SELL Open market or private sale	$8,778 $13.14 p/Share	668 Reduced 1.15%	57,361 Common Stock
Jul 15 2022	SELL Open market or private sale	$10,407 $16.06 p/Share	648 Reduced 1.1%	58,029 Common Stock
Jun 15 2022	SELL Open market or private sale	$7,906 $12.2 p/Share	648 Reduced 1.09%	58,677 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$12,381 $14.6 p/Share	848 Reduced 1.41%	59,325 Common Stock
May 16 2022	SELL Open market or private sale	$29,518 $15.87 p/Share	1,860 Reduced 3.0%	60,173 Common Stock
Apr 18 2022	SELL Open market or private sale	$46,632 $22.87 p/Share	2,039 Reduced 3.18%	62,033 Common Stock
Mar 15 2022	SELL Open market or private sale	$42,982 $21.08 p/Share	2,039 Reduced 3.08%	64,072 Common Stock
Mar 03 2022	SELL Open market or private sale	$5,862 $26.89 p/Share	218 Reduced 0.33%	66,111 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$5,285 $26.69 p/Share	198 Reduced 0.3%	66,329 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$32,382 $26.63 p/Share	1,216 Reduced 1.85%	64,666 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	1,861 Added 2.72%	66,527 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	35,000 Added 34.69%	65,882 Common Stock
Feb 01 2022	SELL Open market or private sale	$33,000 $30.0 p/Share	1,100 Reduced 3.44%	30,882 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	$11,880 $10.8 p/Share	1,100 Added 3.33%	31,982 Common Stock
Jan 04 2022	SELL Open market or private sale	$130,104 $40.23 p/Share	3,234 Reduced 9.48%	30,882 Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	$35,563 $11.29 p/Share	3,150 Added 8.45%	34,116 Common Stock
Dec 06 2021	SELL Open market or private sale	$27,944 $37.61 p/Share	743 Reduced 2.34%	30,966 Common Stock
Dec 03 2021	SELL Open market or private sale	$90,156 $40.98 p/Share	2,200 Reduced 6.49%	31,709 Common Stock
Dec 03 2021	BUY Exercise of conversion of derivative security	$24,838 $11.29 p/Share	2,200 Added 6.09%	33,909 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$119,096 $41.95 p/Share	2,839 Reduced 8.22%	31,709 Common Stock

Linda Llewelyn

Chief People Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account